Muscarinic receptor subtypes modulating smooth muscle contractility in the urinary bladder.
about
GATA-6 mediates human bladder smooth muscle differentiation: involvement of a novel enhancer element in regulating alpha-smooth muscle actin gene expressionAn update on the use of transdermal oxybutynin in the management of overactive bladder disorderOveractive bladder syndrome: Current pathophysiological concepts and therapeutic approachesElementary purinergic Ca2+ transients evoked by nerve stimulation in rat urinary bladder smooth muscle.Changes in muscarinic receptors in the toad urothelial cell line TBM-54 following acrolein treatment.The pharmacological treatment of urinary incontinence.Impaired M3 and enhanced M2 muscarinic receptor contractile function in a streptozotocin model of mouse diabetic urinary bladder.Interstitial cystitis: a review of immunological aspects of the aetiology and pathogenesis, with a hypothesis.AE9C90CB: a novel, bladder-selective muscarinic receptor antagonist for the treatment of overactive bladder.Nerve-released acetylcholine contracts urinary bladder smooth muscle by inducing action potentials independently of IP3-mediated calcium release.Effects of bladder function by early tamsulosin treatment in a spinal cord injury rat modelNew roles for muscarinic receptors in the pathophysiology of lower urinary tract symptoms.Izalpinin from fruits of Alpinia oxyphylla with antagonistic activity against the rat bladder contractilityMuscarinic receptors in the bladder: from basic research to therapeutics.Mixed symptomatology.Bladder instability: a re-appraisal of classical experimental approaches and development of new therapeutic strategies.The intracellular pathway of the acetylcholine-induced contraction in cat detrusor muscle cells.Contractile responses of urinary bladder in an experimental model of chronic renal failurePotentiation of carbachol-induced detrusor smooth muscle contractions by beta-adrenoceptor activation.Molecular mechanisms of detrusor and corporal myocyte contraction: identifying targets for pharmacotherapy of bladder and erectile dysfunctionMuscarinic receptors: their distribution and function in body systems, and the implications for treating overactive bladderPharmacological therapy of female urinary incontinence.Potential therapeutic targets for the treatment of detrusor overactivity.Detrusor contraction--Focus on muscarinic receptors.Comparative pharmacological analysis of Rho-kinase inhibitors and identification of molecular components of Ca2+ sensitization in the rat lower urinary tract.Sickling cells, cyclic nucleotides, and protein kinases: the pathophysiology of urogenital disorders in sickle cell anemia.Trospium chloride: an anticholinergic quaternary ammonium compound for the treatment of overactive bladder.A review of solifenacin in the treatment of urinary incontinence.Muscarinic receptors and ligands in cancer.Progressive changes in detrusor function and micturition patterns with chroinc bladder ischemia.Expression of muscarinic receptor subtypes in tree shrew ocular tissues and their regulation during the development of myopiaHEF-19-induced relaxation of colonic smooth muscles and the underlying mechanismsIn vivo and in vitro pharmacological characterization of SVT-40776, a novel M3 muscarinic receptor antagonist, for the treatment of overactive bladder.Fesoterodine for the treatment of urinary incontinence and overactive bladder.Inflammation induced by mast cell deficiency rather than the loss of interstitial cells of Cajal causes smooth muscle dysfunction in W/W(v) mice.A Guide to Medications Inducing Salivary Gland Dysfunction, Xerostomia, and Subjective Sialorrhea: A Systematic Review Sponsored by the World Workshop on Oral Medicine VI.International Children's Continence Society's recommendations for therapeutic intervention in congenital neuropathic bladder and bowel dysfunction in children.Pharmacokinetics and toxicity of antimuscarinic drugs for overactive bladder treatment in females.Cardiovascular effects of antimuscarinic agents in overactive bladder.Solifenacin: pharmacology and clinical efficacy.
P2860
Q24318949-1AF94314-556E-4BD5-BF0C-71E6DE2250D2Q26749105-63DE8FCA-1B58-4E31-96C9-68698D5AA818Q27022279-03E56407-BD7E-46A2-9EE2-0D27C5F53D1CQ30775253-38AD60CD-5F6F-4757-BDDE-721388FC2544Q33302963-B5BFE41D-DF4E-47A4-99FF-AC7F2F83CC46Q33778812-8D5CD0DA-F973-48AC-82F9-4B01C6163233Q33821180-0151770F-4608-4B5C-B036-6D1243A10E19Q33904356-04A611DD-01A7-458B-BDFC-FA08E189BB52Q34112974-75C83433-41E4-4DC3-BBCD-5B064838BE62Q34150201-B44605FC-3959-4421-A8B3-1E8B3F61EC01Q34178276-A1D11003-4C21-49AF-A113-630EBB3D9BDBQ34334942-F879BA65-9DF5-4F7A-BB31-2F54BD232129Q34367187-D7C3DF77-6329-4CFC-8DB8-E3DA84925090Q34564708-8B02D549-7B19-4767-9FD1-349C8840CF2FQ34601951-D3ABC4F8-86B0-44D1-B81F-2301F85C16E7Q34746996-070CCE21-7040-4362-86CD-890587F34E13Q35044747-B3F7EB4F-D432-4FFF-97D1-621834D30EC7Q35184515-A9F3BE8A-A36B-4799-A1BF-743B870F1B3DQ35381711-9502E837-8938-4ECD-94ED-86B2C7385A0AQ35545755-DC85DC01-B14D-4838-8E5E-7B8F87A191DDQ35546189-27115B4E-F620-42DA-A853-3448F46E3259Q35697774-606212E6-F836-44A9-A4A3-01B33C3D407FQ35753357-415C5756-297E-4572-9613-C858D735606BQ35951022-C3F9D3A1-4686-4FAA-9D8A-6D17AB16631AQ36004804-40024527-CD52-4F12-9B1C-2EAF300BDC6FQ36056143-3CDE19CD-4E3B-4FD4-B477-5278B0A029FCQ36192782-CABDDEBC-88C5-420A-876A-2CB505C5955BQ36822864-4301D478-B265-4F7F-87EC-68735C513AACQ37100030-A2D0E6B1-DD5B-4FCF-A364-2FDF10CD4D5CQ37105640-0068F149-3936-4663-8DCD-E61B7A1AB970Q37112727-B23CD1D4-AFB1-492B-9BF0-A75A599FA6D8Q37118852-976AD661-4FC2-4E27-9E29-3493CC0992CAQ37230811-23FD92F3-9401-49C3-9BF4-F03CC3714AC1Q37429813-CE0BA712-C79D-452C-A062-47609F05C6A9Q37550372-26BF63BF-6274-4412-9244-CC1E88BBD102Q37653402-79449711-4795-40D6-B33C-74AFF46D1B96Q38005364-E5F1CFA6-D7B6-43E0-AFD2-C845BEB006A1Q38032608-DE109FBE-4D8E-4E88-B761-CA6E8F09B3C1Q38116972-C69E46AF-5B48-4267-9FC5-05C7B6117036Q38177369-B771383B-7A4A-4049-BE13-195E7F34A7B2
P2860
Muscarinic receptor subtypes modulating smooth muscle contractility in the urinary bladder.
description
1999 nî lūn-bûn
@nan
1999 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի հունվարին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Muscarinic receptor subtypes m ...... tility in the urinary bladder.
@ast
Muscarinic receptor subtypes m ...... tility in the urinary bladder.
@en
Muscarinic receptor subtypes m ...... tility in the urinary bladder.
@nl
type
label
Muscarinic receptor subtypes m ...... tility in the urinary bladder.
@ast
Muscarinic receptor subtypes m ...... tility in the urinary bladder.
@en
Muscarinic receptor subtypes m ...... tility in the urinary bladder.
@nl
prefLabel
Muscarinic receptor subtypes m ...... tility in the urinary bladder.
@ast
Muscarinic receptor subtypes m ...... tility in the urinary bladder.
@en
Muscarinic receptor subtypes m ...... tility in the urinary bladder.
@nl
P1433
P1476
Muscarinic receptor subtypes m ...... tility in the urinary bladder.
@en
P2093
P304
P356
10.1016/S0024-3205(98)00581-5
P407
P577
1999-01-01T00:00:00Z